Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity.

Source:http://linkedlifedata.com/resource/pubmed/id/11920625

Int. J. Cancer 2002 Apr 1 98 4 624-9

Download in:

View as

General Info

PMID
11920625